Sign In
Sign Up
Two Blokes
Ashvattha Therapeutics to Present Phase 2 DME and Wet AMD Data at Clinical Trials at the Summit and MaculArt
click to rate
Posted by
Two Blokes
Jun 10
- Filed in
Stock
- 6 views
Ashvattha will present Phase 2 data on migaldendranib, a subcutaneous therapy for DME and wet AMD, which could offer a more patient-friendly alternative to current injection-based treatments
